Patient and Physician Behavior
Featured Topics
Lead story
Other featured articles
-
Prescription Opioid Use in General and Pediatric Emergency Departments
Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.
Posted in -
Extended-Release Formulation and Medication Adherence
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.
Posted in -
Opioid Prescribing Decreases After Learning of a Patient’s Fatal Overdose
Results of the randomized trial show opioid prescribing decreases after a clinician learns of a patient’s fatal overdose.
Posted in -
It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid
To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.Posted in
About this section
Patients as well as providers must take responsibility in improving healthcare, but human fallibility can impede success. The Schaeffer Center fosters supportive and effective ways to improve the decision-making of all parties for healthier results.
Our Experts On Patient and Physician Behavior
Our Work In Patient and Physician Behavior
-
Electronic ‘Nudges’ May Improve Safety in Opioid Prescribing Among California Doctors, Study Finds
Researchers observed a 23% drop in opioid prescriptions and a 27% increase in prescriptions for naloxone.
Categorized in -
The Eldercare Facility Ordinance of Los Angeles: A Synthetic Control Analysis of Residential Care Development and Growth
Using California State Department of Social Services residential care and census place data, this study compares the pre and post effect of the ordinance on the number of large residential care facilities developed in Los Angeles with a comparison group using synthetic control analysis.
Categorized in -
Here’s How Public Health Messaging Can Help With the Next Phase of the Pandemic
As COVID-19 cases increase and officials warn of a potential new surge, confusion still bedevils our public health messaging.
Categorized in -
Use of Prescription Medications with Cardiovascular Adverse Effects Among Older Adults in the United States
Schaeffer experts examined the association between the concurrent use of prescription medications with known risk of a major adverse cardiovascular event (MACE) (“MACE medications”) and the risk of such events among older adults.
Categorized in -
Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law
A new study by experts at the USC Schaeffer Center for Health Policy and Economics and Kaiser Permanente finds Naloxone prescriptions increased while opioid prescriptions decreased.
Categorized in -
Racial Disparities in Accessing Treatment for Substance Use Highlights Work to Be Done
Older Americans are increasingly seeking treatment for substance use disorders with older Black Americans who start treatment being much more likely to have their treatment terminated and not finish compared to white adults.
Categorized in